Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circadian pathway genes in relation to glioma risk and outcome.

Cancer causes & control : CCC - 1 Jan 2014

Madden Melissa H, Anic Gabriella M, Thompson Reid C, Nabors L Burton, Olson Jeffrey J, Browning James E, Monteiro Alvaro N, Egan Kathleen M

Abstract excerpt

PURPOSE: There is growing evidence that circadian disruption may alter risk and aggressiveness of cancer. We evaluated common genetic variants in the circadian gene pathway for associations with glioma risk and patient outcome in a US clinic-based case-control study. METHODS: Subjects were genotyped for 17 candidate single nucleotide polymorphisms in ARNTL, CRY1, CRY2, CSNK1E, KLHL30, NPAS2, PER1, PER3, CLOCK,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alleles

Share to Case-Control Studies

Share to Circadian Rhythm

Share to Glioma

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 24135790
DOI: 10.1007/s10552-013-0305-y
PMCID: PMC3947318

Genes

CLOCK
MYRIP
PER1
CRY1
KLHL30
NPAS2
PER3
CRY2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circadian pathway genes in relation to glioma risk and outcome.PMID 24135790Read ↗

Differential expression of the circadian clock network correlates with tumour progression in gliomas.Semantic proximity Read ↗

Exploring Transcriptomic Databases: Unraveling Circadian Gene Disruptions in Low Grade GliomaSemantic proximity Read ↗

Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapySemantic proximity Read ↗

Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignanciesSemantic proximity Read ↗

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Circadian gene variants in cancer.Semantic proximity Read ↗

Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.Semantic proximity Read ↗

Bioinformatic Analysis of Genetic Changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3 and NPAS2 Proteins in HCC PatientsSemantic proximity Read ↗

Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.Semantic proximity Read ↗

Roles of circadian clocks in cancer pathogenesis and treatmentSemantic proximity Read ↗

The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic StrategiesSemantic proximity Read ↗

Circadian genesPer1andPer2increase radiosensitivity of gliomain vivoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.